Teva Can't Nix ERISA Suit Over Excessive Fee Allegations
A Pennsylvania federal judge on Tuesday denied a bid by Teva Pharmaceuticals USA Inc. to toss a proposed class action accusing the drugmaker of saddling its 401(k) plan participants with excessive fees,...To view the full article, register now.
Already a subscriber? Click here to view full article